Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada
Sponsor: Nanochon, Inc.
Summary
The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
Official title: A First in Human (FIH) Early Feasibility Study (EFS) to Evaluate the Safety and Performance of the Nanochon Chondrograft™ Implant for Re-surfacing of Cartilage Lesions
Key Details
Gender
All
Age Range
22 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-02
Completion Date
2027-08
Last Updated
2026-03-18
Healthy Volunteers
No
Conditions
Interventions
Nanochon Chondrograft
Mini arthrotomy or arthroscopic surgical implantation of the Nanochon Chondrograft
Locations (3)
Fraser Orthopaedic Institute
New Westminster, British Columbia, Canada
University of British Columbia
Vancouver, British Columbia, Canada
Michael Garron Hospital
Toronto, Ontario, Canada